- Home
- A-Z Publications
- Letters in Drug Design & Discovery
- Previous Issues
- Volume 19, Issue 6, 2022
Letters in Drug Design & Discovery - Volume 19, Issue 6, 2022
Volume 19, Issue 6, 2022
-
-
Saponins-uptake and Targeting Issues for Brain-specific Delivery for Enhanced Cell Death Induction in Glioblastoma
By P.K. SureshSaponins represent a category of diverse, natural glycoside molecules that belong to the triterpenoid or the steroid class. They vary in terms of their solubility and permeability characteristics and are classifiable based on the biopharmaceutics classification system. They have drug delivery potential as surfactants that can solubilize cholesterol in the plasma membrane of tumorigenic cells. Glioblastoma is an important malig Read More
-
-
-
Screening of a Library for Factor VIIa Inhibitors
Authors: Alexandre Bridoux and Shaker A. MousaBackground: As an alternative to the anticoagulant’s strategy using direct or indirect anti-Xa drugs, considering other targets upstream in the coagulation cascade such as anti-Factor VIIa could represent an effective and safer strategy in coagulation and pathological angiogenesis. Objective: The objective of the study was to assess a high technology methodology composed of virtual screening, anticoagulant, and a Read More
-
-
-
Design, Synthesis and In Vitro Anticancer Activity of Benzo[c]chromen-6- one-linked 1,2,3-Triazole
Background: The 1,2,3-triazole hybrids and conjugates containing natural or related compounds motif demonstrate diverse biological activities, including anticancer, antimicrobial, antitubercular, antiviral, antidiabetic, antimalarial, anti-leishmanial, and neuroprotective ones. Among a wide range of pharmacological applications, considerable attention is paid to the study of anticancer activity. In anticancer research, combini Read More
-
-
-
Synthesis and Studies of Anticancer and Antimicrobial Activity of New Phenylurenyl Chalcone Derivatives
Authors: Güneş Y. Akdeniz, Hülya Akgün, Özlem B. Özakpınar, Merve Duracık, Mehmet Öztürk, Evin İşcan and Faika BaşoğluBackground: Phenylurenyl chalcone structures have the potential to act as a scaffold in anticancer drug discovery. Methods: N-Phenethyl-N'-{4-[(2E)-3-phenylprop-2-enoyl]phenyl}urea, 4/3-[(2E)-3-substitutedphenylprop-2- enoyl]phenyl}-N-phenylurea,4/3-[(2E)-3-substitutedphenyl. prop-2-enoyl]phenyl}-N-methylphenyl urea and {4/3-[(2E)-3-substitutedphenylprop-2-enoyl]phenyl}-Nethylphenyl urea derivatives(1-35) were p Read More
-
-
-
Self-double Emulsified Drug Delivery System of Pyridostigmine Bromide Augmented Permeation Across Caco-2 Cells
Authors: Shiwani Dharwal, Neha Bajwa, Jitender Madan, Uttam K. Mandal, Kamalinder K. Singh and Ashish BaldiAim: The study aims to enhance the permeability of pyridostigmine bromide by developing a self-double emulsifying drug delivery system (SDEDDS) and enteric-coated spheroids. Background: Pyridostigmine bromide is a reversible anticholinesterase used to treat Myasthenia Gravis, reverse neuromuscular blockade, and prevent nerve gas (i.e., soman) poisoning. It is readily soluble in water, but its poor and irregular intestinal Read More
-
-
-
Synthesis, Biological Evaluation, and Docking Analysis of Novel Tetrahydrobenzothiophene Derivatives
Authors: Raghav Mishra, Nitin Kumar and Neetu SachanBackground: The role of retinoic acid receptor-related orphan receptors in cancer development has raised the interest to develop multi-functional agents. Objective: The main purpose of this work was in silico design and synthesis of potential anticancer candidates with antioxidant effect. Methods: The compounds were designed based on their docking studies with respect to the RORγt receptor. Using the Gewald protocol, Read More
-
-
-
An <I>In-silico</I> Approach to Identify Potential Drug Molecules for Alzheimer’s Disease: A Case Involving Four Therapeutic Targets
Background: Computational methods in the ‘omics’ era have proved to be a boon in the drug discovery field. Bioinformatics and cheminformatics databases and tools complement the successful discovery of promising lead compounds in the treatment of several disease conditions, including neurodegenerative diseases, such as Alzheimer’s Disease (AD). However, commercially available drugs in the market to alleviate the dis Read More
-
-
-
Determination of Hybrid TSPO Ligands with Minimal Impact of SNP (rs6971) through Molecular Docking and MD Simulation Study
Authors: Anupriya Adhikari, Anwesh Pandey, Devesh Kumar and Anjani K. TiwariBackground: In an endeavor to ascertain high-affinity TSPO ligands with minimal single nucleotide polymorphism (SNP), six hybrid molecules have been identified as new leads for future inflammation PET imaging. Objective: Genesis for chemical design was encouraged from structural families of well-known ligands FEBMP and PBR28/ DAA1106 that have demonstrated remarkable TSPO binding characteristics. Methods: All prop Read More
-
Volumes & issues
-
Volume 21 (2024)
-
Volume 20 (2023)
-
Volume 19 (2022)
-
Volume 18 (2021)
-
Volume 17 (2020)
-
Volume 16 (2019)
-
Volume 15 (2018)
-
Volume 14 (2017)
-
Volume 13 (2016)
-
Volume 12 (2015)
-
Volume 11 (2014)
-
Volume 10 (2013)
-
Volume 9 (2012)
-
Volume 8 (2011)
-
Volume 7 (2010)
-
Volume 6 (2009)
-
Volume 5 (2008)
-
Volume 4 (2007)
-
Volume 3 (2006)
-
Volume 2 (2005)
-
Volume 1 (2004)
Most Read This Month
Article
content/journals/lddd
Journal
10
5
false
en
